Chanelle Pharma this week announced the appointment of Sébastien Boussemart as Head of Animal Health, a strategic leadership role designed to accelerate the company’s growth, strengthen global operations, and advance its vision as a fully integrated B2B partner of choice for the animal health industry.
In this role, Sébastien will lead the Animal Health division, overseeing the end-to-end business from development and manufacturing to commercialisation.
His appointment comes as Chanelle continues to reinforce its position as a fully integrated partner delivering differentiated value to customers worldwide.
Angelo Gatto, Chief Executive Officer of Chanelle Pharma, said Sébastien joins the company at an exciting moment.
“The NEW Chanelle is evolving into a global and fully integrated player, combining development, manufacturing, and commercialisation under one roof.
“His international history in Animal Health and proven leadership will be pivotal as we accelerate innovation and create long-term value for our partners.”
Sébastien Boussemart said that he is thrilled to join Chanelle Pharma at such a transformative time.
“The company’s vision to expand the end-to-end B2B partnership is unique in the industry.
“I look forward to leading the Animal Health business, supporting our talented teams, and helping our partners access reliable, high-quality solutions while unlocking new growth opportunities,” he concluded.
